JCR Pharmaceuticals
JCR has been proactively engaged in research and development (R&D) of biopharmaceuticals based on recombinant DNA technologies. Learn more
Launch date
Employees
Market cap
AUD986m
Enterprise valuation
AUD1.0b (Public information from Sep 2024)
Share price
JPY663 4552.T
Kobe Hyogo Prefecture (HQ)
Authorizing premium user...